Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
|Articles|March 3, 2021
TruCLEAN Sterile Mops
Author(s)Perfex Corporation
Perfex Corporation launches TruCLEAN Sterile product line for high-grade cleanroom use.
With decades of research and innovation Perfex introduces TruCLEAN® Sterile, a focused line of next-generation cleaning products ideal for use in high-grade cleanrooms. The product line includes sponge mops, mop covers, and cleanroom wipes, gamma sterilized and validated sterile per the Association for the Advancement of Medical Instrumentation guidelines. Each product is processed and packaged in an ISO Class 5 cleanroom with biodegradable packaging materials.
Perfex Corporation
32 Case Street
Poland, NY 13431 USA
Related to this article
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.